31 januari 2019: lees ook dit artikel: 

https://kanker-actueel.nl/tcm-traditionele-chinese-medicijnen-kruiden-verbeteren-ziektevrije-tijd-met-15-procent-voor-operabele-darmkanker-stadium-iii-in-vergelijking-met-geen-tcm-darmtumoren-aan-linkerkant-hadden-beste-ziektevrije-tijd-56-vs-42-procent-voor-geen-tcm.html

20 augustus 2009: Bron: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 May;29(5):439-41

Injecties met Chinese kruiden - Shanqi Fuzheng - naast chemo verbetert signifiant kwaliteit van leven door sterke vermindering van misselijkheid en braken en verbetert significant mediane overleving bij vergevorderde darmkanker, in vergelijking met alleen chemo (FOX regime) aldus gerandomiseerde studie bij 152 patienten.  De effectiviteit (CR +PR) was 63.2% (48/76) in de Shenqui groep en 46.1% (35/76) in de controle groep, een significant verschil (P < 0.05). Van Peter, waarvoor dank, kregen we informatie dat Shenqui een kruidenstofje is dat ook in Artemisinin zit, maar lees verdere informatie onder Artemisinin informatie.

1: Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 May;29(5):439-41. Links

[Effect of Shenqi Fuzheng injection combined with chemotherapy in treating advanced colorectal carcinoma]
[Article in Chinese]

 
Liang QL, Pan DC, Xie JR.
Center for Oncology, Affiliated Hospital of Guangdong Medical College, Guangdong. lliangql@163.com
OBJECTIVE: To compare the therapeutic effect and toxicity of chemotherapy, used alone or in combined with Shenqi Fuzheng Injection (SFI), for the treatment of advanced colorectal carcinoma (ACRC). METHODS: One hundred and fifty-two patients with ACRC were equally randomized by digital table, to the treated group, treated by chemotherapy of FOLFOX regimen combined with SFI, and the control group treated by FOLFOX regimen alone. The therapeutic effect and adverse reaction of the treatment in patients were assessed. 
 
RESULTS: The effective rate (CR +PR) was 63.2% (48/76) in the treated group and 46.1% (35/76) in the control group, showing significant difference between the two groups (P < 0.05). The median survival time in the two groups was 31 weeks and 28 weeks respectively. CD4/CD8 ratio was significantly increased in the treated group (1.56 +/- 0.21, 1.64 +/- 0.28, P < 0.05), but significantly decreased in the control group (1.58 +/- 0.22, 1.46 +/- 0.33, P < 0.01). Quality of life in the former group was higher than that in the latter group (P < 0.05). Times/case of nausea, vomiting, leukopenia occurring in the control group was more than those in the treated group A (P < 0.05).
 
CONCLUSION: By combining with SFI, some adverse reactions of chemotherapy (such as nausea, vomiting, leukopenia) and its influence on patients' immunity could be alleviated in treating ACRC, which might enhance the efficacy of chemotherapy, and improve the quality of life and prolong the median survival time in patients.
PMID: 19673337 [PubMed - in process)

 


Plaats een reactie ...

Reageer op "Darmkanker: Chinese kruiden - injecties met Shenqui (zit ook in Artemisinin) - als aanvulling op chemo bij vergevorderde darmkankerpatienten geeft een significant betere kwaliteit van leven en mediaan een significante verbetering van de overlevingstijd."


Gerelateerde artikelen
 

Gerelateerde artikelen

TCM - Traditionele Chinese >> ShenQi FuZheng Injectie aanvullend >> TCM - Traditionele Chinese >> Chinese Kruiden - TCM alleen >> Darmkanker: Injecties met >> Darmkanker: Chinese kruid >> Chinese medicijnen - TCM: >>